Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Medicine (Cambridge, Mass.)|October 19, 2023
Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH/GPX4 pathwayXingjie Wang, Tianli Shen, Jie Lian, et al.
Experimental & Molecular Medicine|September 13, 2022
Activating SIRT3 in peritoneal mesothelial cells alleviates postsurgical peritoneal adhesion formation by decreasing oxidative stress and inhibiting the NLRP3 inflammasomeTianli Shen, Yunhua Wu, Xingjie Wang, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|June 25, 2023
Visual Observation of Abdominal Adhesion Progression Based on an Optimized Mouse Model of Postoperative Abdominal AdhesionsZijun Wang, Enmeng Li, Cancan Zhou, et al.
BMC Gastroenterology|December 31, 2025
HMGB1-enhanced autophagic degradation of E-cadherin facilitates mesothelial trans-differentiation and postoperative peritoneal adhesionXuetao Yuan, Shuting Yang, Chao Qu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2020
DKK2 blockage-mediated immunotherapy enhances anti-angiogenic therapy of Kras mutated colorectal cancerJiajia Hu, Zhengting Wang, Zhengxi Chen, et al.
European Journal of Pharmacology|December 18, 2023
Luteolin blocks the ROS/PI3K/AKT pathway to inhibit mesothelial-mesenchymal transition and reduce abdominal adhesionsYiwei Ren, Gan Li, Enmeng Li, et al.
Journal of Ethnopharmacology|September 30, 2023
Quercetin inhibits mesothelial-mesenchymal transition and alleviates postoperative peritoneal adhesions by blocking the TGF-β1/PI3K/AKT pathwayGan Li, Yiwei Ren, Enmeng Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 30, 2023
A bionic "Trojan horse"-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapyTianli Shen, Shuanying Yang, Xiaoyan Qu, et al.
ACS Nano|October 4, 2024
Innovative Oral Nano/Gene Delivery System Based on Engineered Modified <i>Saccharomyces cerevisiae</i> for Colorectal Cancer TherapyTianli Shen, Xuejun Sun, Shuanying Yang, et al.
Journal of Advanced Research|September 3, 2025
FSP1 reduces exogenous coenzyme Q10 and inhibits ferroptosis to alleviate intestinal ischemia-reperfusion injuryTianli Shen, Xingjie Wang, Junxiang Zhang, et al.
Pageof 2